Cargando…
Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of Care
Hypertrophic cardiomyopathy (HCM) is one of the more common hereditary cardiac conditions. According to presence or absence of outflow obstruction at rest or with provocation, a more common (about 60–70%) obstructive type of the disease (HOCM) has to be distinguished from the less common (30–40%) no...
Autor principal: | Faber, Lothar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590958/ https://www.ncbi.nlm.nih.gov/pubmed/26556411 http://dx.doi.org/10.1155/2014/464851 |
Ejemplares similares
-
Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
por: Scholtz, Smita, et al.
Publicado: (2023) -
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: El Masry, Hicham, et al.
Publicado: (2008) -
Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy
por: Aksu, Tolga, et al.
Publicado: (2016) -
Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
por: Arévalos, Victor, et al.
Publicado: (2021) -
Septal Ablation in Obstructive Hypertrophic Cardiomyopathy
(oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)